Interferon Restores Antigen Presentation and Sensitizes Medulloblastoma to T Cell Killing
Tanja Eisemann(Heidelberg University), Robert J. Wechsler‐Reya(Columbia University Irving Medical Center)
Cited by 0
Related Papers
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|607
Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
|Nature Communications|2019|84
The long noncoding RNA <i>lnc-HLX-2-7</i> is oncogenic in Group 3 medulloblastomas
|Neuro-Oncology|2020|42
Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterases
|Science Translational Medicine|2022|37